B-Cell Non-Hodgkin Lymphoma — Trials

B-Cell Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

6,181 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,757
Recruiting: 905
Ph III recruiting: 103
Growth YoY: +3.6%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (954)

clinicaltrialsPublishedShowing 801–850 of 982 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07022223	Orelabrutinib Combined With Rituximab as First-line Systemic Treatment for Marginal Zone Lymphoma	recruiting	Phase 2	51	Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER	1	Jun 15, 2025	clinicaltrials
NCT07014943	High-Dose Gemcitabine, Busulfan, and Thiotepa Followed by ASCT in Primary Central Nervous System Lymphoma	recruiting	Phase 2	34	Sichuan UniversityOTHER	1	Jun 11, 2025